ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "MI Aftercare: The Beat Goes On—With or Without Beta-Blockers 🥁➡️❤️"
Episode Synopsis
📘 New Evidence from NEJM In a large meta-analysis of 17,801 patients with preserved LVEF after MI, beta-blockers did not reduce death, recurrent MI, or heart failure. Event rates were low, and outcomes were similar with or without therapy. 🫀📊 This clarifies practice for a growing post-MI population with LVEF ≥50%—precision matters more than tradition. 🎯 Full study: New England Journal of Medicine (2025). #Cardiology 💙 #ClinicalEvidence #MI #HeartHealth
In God we trust